HC Wainwright reissued their buy rating on shares of Cibus (NASDAQ:CBUS - Free Report) in a research report released on Friday morning,Benzinga reports. The brokerage currently has a $25.00 price target on the stock. HC Wainwright also issued estimates for Cibus' Q1 2025 earnings at ($0.66) EPS, Q2 2025 earnings at ($0.67) EPS, Q3 2025 earnings at ($0.69) EPS, Q4 2025 earnings at ($0.70) EPS and FY2029 earnings at $1.36 EPS.
Separately, Canaccord Genuity Group cut their price objective on shares of Cibus from $20.00 to $18.00 and set a "buy" rating on the stock in a report on Wednesday, January 22nd.
Read Our Latest Report on CBUS
Cibus Trading Down 5.0 %
Shares of CBUS stock traded down $0.11 on Friday, reaching $2.09. 160,197 shares of the stock were exchanged, compared to its average volume of 167,137. Cibus has a twelve month low of $1.80 and a twelve month high of $23.18. The company has a market capitalization of $55.29 million, a price-to-earnings ratio of -0.09 and a beta of 2.04. The business's 50 day moving average price is $2.32 and its 200 day moving average price is $3.28.
Cibus (NASDAQ:CBUS - Get Free Report) last released its quarterly earnings data on Thursday, March 20th. The company reported ($0.87) EPS for the quarter, missing analysts' consensus estimates of ($0.68) by ($0.19). The business had revenue of $1.21 million during the quarter, compared to analysts' expectations of $1.13 million. Cibus had a negative net margin of 10,724.78% and a negative return on equity of 28.17%. Equities research analysts forecast that Cibus will post -2.96 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the company. IFP Advisors Inc purchased a new position in shares of Cibus during the fourth quarter worth approximately $36,000. B. Riley Wealth Advisors Inc. purchased a new position in Cibus during the 3rd quarter worth $44,000. Virtu Financial LLC acquired a new position in Cibus in the third quarter valued at $48,000. HighTower Advisors LLC increased its stake in Cibus by 20.6% in the third quarter. HighTower Advisors LLC now owns 16,125 shares of the company's stock valued at $52,000 after purchasing an additional 2,750 shares during the period. Finally, Sei Investments Co. purchased a new stake in shares of Cibus in the fourth quarter valued at about $49,000. Hedge funds and other institutional investors own 33.81% of the company's stock.
About Cibus
(
Get Free Report)
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Further Reading
Before you consider Cibus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cibus wasn't on the list.
While Cibus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
